Aadi Bioscience to Present New Non-clinical Data Highlighting Combinability of nab-Sirolimus at the American Association for Cancer Research (AACR) Annual MeetingPRNewsWire • 04/09/24
Is Aadi Bioscience (AADI) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 04/03/24
Is Aadi Bioscience (AADI) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 03/18/24
Aadi Bioscience Presents New Subgroup Analysis of Patients with Advanced Malignant PEComa of Gynecologic Origin Treated with nab-Sirolimus at Society of Gynecologic Oncology (SGO)PRNewsWire • 03/17/24
Aadi Bioscience, Inc. (AADI) Reports Q4 Loss, Misses Revenue EstimatesZacks Investment Research • 03/13/24
Aadi Bioscience Announces Financial Results for the Fourth Quarter and Full-Year 2023 and Provides Corporate UpdatePRNewsWire • 03/13/24
Aadi Bioscience to Report Fourth Quarter and Full-Year 2023 Results and Corporate UpdatePRNewsWire • 03/06/24
Aadi Bioscience to Present Multiple Posters at the American Association for Cancer Research (AACR) Annual Meeting 2024PRNewsWire • 03/05/24
Aadi Bioscience Announces Publication of Long-Term Efficacy and Safety Data Further Supporting FYARRO® for the Treatment of Malignant PEComaPRNewsWire • 03/01/24
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers SymposiumPRNewsWire • 01/26/24
Aadi Bioscience Announces Poster Presentations at the 2024 American Society of Clinical Oncology (ASCO) Gastrointestinal (GI) Cancers SymposiumPRNewsWire • 01/19/24
Top 3 Health Care Stocks That Are Preparing To Pump This Month - Durect (NASDAQ:DRRX), Aadi Bioscience (NASDAQ:AADI)Benzinga • 12/18/23
Aadi Bioscience Reports Interim Results from PRECISION1 Trial of nab-Sirolimus Demonstrating Anti-Tumor Activity in Solid Tumors with TSC1 or TSC2 Inactivating AlterationsPRNewsWire • 12/14/23
How Much Upside is Left in Aadi Bioscience, Inc. (AADI)? Wall Street Analysts Think 509.98%Zacks Investment Research • 11/29/23
Aadi Bioscience Reports Financial Results for the Third Quarter 2023 and Provides Corporate UpdatePRNewsWire • 11/08/23
Aadi Bioscience Announces Poster Presentations on Nab-Sirolimus at the International Gynecologic Cancer Society (IGCS) 2023 Annual Global MeetingPRNewsWire • 10/19/23
Aadi Bioscience Announces Poster Presentations at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer TherapeuticsPRNewsWire • 10/12/23
Aadi Bioscience Announces Poster Presentations at the North American Neuroendocrine Tumor Society (NANETS) 2023 Multidisciplinary NET Medical SymposiumPRNewsWire • 10/05/23
Aadi Bioscience Grants New CEO Dave Lennon, Ph.D. Inducement Award Under Nasdaq Listing Rule 5635 (c)(4)PRNewsWire • 10/03/23